Oxford Biodynamics PLC (LON:OBD)’s stock price was down 4.1% during mid-day trading on Thursday . The stock traded as low as GBX 87 ($1.14) and last traded at GBX 93 ($1.22), approximately 79,319 shares were traded during mid-day trading. An increase of 17% from the average daily volume of 67,675 shares. The stock had previously closed at GBX 97 ($1.28).
Separately, Shore Capital reissued a “house stock” rating on shares of Oxford Biodynamics in a research note on Friday, October 25th.
The company’s fifty day moving average price is GBX 109.94 and its 200 day moving average price is GBX 106.27. The company has a market cap of $85.85 million and a PE ratio of -30.92.
Oxford Biodynamics (LON:OBD) last released its quarterly earnings results on Tuesday, December 10th. The biotechnology company reported GBX (3) (($0.04)) earnings per share for the quarter.
In other news, insider Stephen Charles Diggle bought 18,309 shares of the company’s stock in a transaction on Tuesday, December 10th. The shares were purchased at an average price of GBX 104 ($1.37) per share, with a total value of £19,041.36 ($25,047.83).
About Oxford Biodynamics (LON:OBD)
Oxford BioDynamics Plc, a biotechnology company, discovers and develops biomarkers for use within the pharmaceutical and biotechnology industry primarily in the United Kingdom and Malaysia. The company provides EpiSwitch, a proprietary technology platform for the discovery, evaluation, validation, and monitoring of epigenetic biomarkers known as chromosome conformation signatures.
Read More: Guidelines for Successful Channel Trading
Receive News & Ratings for Oxford Biodynamics Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Oxford Biodynamics and related companies with MarketBeat.com's FREE daily email newsletter.